Adult

Cefiderocol

Warning

General Information

Siderophore cephalosporin antibiotic

Do NOT use if patient has a history of severe penicillin allergy.  If in doubt, discuss with Micro/ID.

Restricted formulary antimicrobial: For details see OUH netFormulary

AWaRe antibiotic classification: 'Reserve'. All indications to be discussed with Micro/ID.

For all information regarding interactions, contraception, pregnancy and breastfeeding and additional information, see BNF

Standard dose

  Intravenous dose

Standard dose

2g TDS

Augmented renal clearance with CrCL of 120 mL/min or more

2g QDS*

*QDS dosing can contribute a large sodium load if the dose is administered in sodium chloride 0.9% infusion fluid. Consider choice of infusion fluid when dosing QDS. 

Renal and hepatic impairment

Renal impairment

Creatinine clearance**

(mL/min)

Intravenous dose

120 and above

Dose as in augmented renal clearance

60-119

Dose as in normal renal function

30-59

1.5g TDS

15-29

1g TDS

Less than 15

1g BD

HDF/High flux/PD

Dialysed; give post-dialysis on dialysis days

Dose as in CrCl less than 15 mL/min

**dose ranges use creatinine clearance, rather than eGFR

Note: Doses are based on Renal Drug Database

 

Hepatic impairment

No dose adjustment necessary.

References

  1. Shionogi. Fetcroja 1 g powder summary of product characteristics. Electronic medicines compendium. Last revision of the text 01/03/24. Accessed via www.medicines.org.uk Accessed 3/3/26.
  2. British National Formulary. Cefiderocol. BNF online accessed via www.medicinescomplete.com  Accessed 3/3/26.
  3. The Renal Drug Database. Cefiderocol. Last updated 31/10/23. Accessed via https://renaldrugdatabase.com Accessed 3/3/26.
  4. Sanford Guide [online]. Cefiderocol. Last updated 2/2/26. Accessed via https://webedition.sanfordguide.com. Accessed 3/3/26.

Editorial Information

Last reviewed: 03 Mar 2026

Next review date: 01 Mar 2029

Author(s): AMST.